MET Inhibition in Metastatic NSCLC “In the Spotlight” - a podcast by ReachMD

CME credits: 0.25

Valid until: 25-10-2024

Claim your CME credit at https://reachmd.com/programs/cme/met-inhibition-in-metastatic-nsclc-in-the-spotlight/14786/

Drs. Paul Paik, Keith Kerr, and Ross Camidge take us through testing considerations for MET exon 14 skipping mutations and optimal treatment approaches once a mutation is detected. They also discuss the emerging data and how to apply what we’re learning to everyday clinical practice.

=

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD